End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | 301M 25.08B | Sales 2025 * | 334M 27.83B | Capitalization | 965M 80.46B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 3.83 x |
Net Debt 2024 * | 187M 15.62B | Net Debt 2025 * | 106M 8.86B | EV / Sales 2025 * | 3.21 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 65.34% |
Latest transcript on Theravance Inc
Managers | Title | Age | Since |
---|---|---|---|
Pavel Raifeld
CEO | Chief Executive Officer | 40 | 20/20/20 |
Stephen Basso
DFI | Director of Finance/CFO | 58 | 21/23/21 |
Marianne Zhen
AUD | Comptroller/Controller/Auditor | 55 | 01/14/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 12/18/12 | |
Director/Board Member | 53 | 01/23/01 | |
Jules Haimovitz
BRD | Director/Board Member | 73 | 12/18/12 |
1st Jan change | Capi. | |
---|---|---|
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+19.35% | 332B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.04% | 145B |